PureGen: Radiographic Analysis of Fusion for ACDF
PureGen Osteoprogenitor Cell Allograft: A Radiographic Analysis of Rate and Quality of Fusion in Patients Undergoing Anterior Cervical Discectomy and Fusion (ACDF)
Sponsor: Alphatec Spine, Inc.
Terminated
Product is no longer on the market
Other terminated trials from Alphatec Spine, Inc.
- Lumbar Degenerative Disc Disease · Phase NA · Nov 2013
- Vertebral Compression Fractures · Phase NA · Jul 2013
- Lumbar Degenerative Disc Disease
More terminations from Alphatec Spine, Inc.
Other Cervical Degenerative Disc Disease trials with similar outcome
This observational or N/A phase trial investigates Cervical Degenerative Disc Disease and is currently terminated or withdrawn. Alphatec Spine, Inc. leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Apr 2022 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Apr 2022 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Feb 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alphatec Spine, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .